Sub Banner Image

Can J&J Navigate Stelara, Talc Suits, Tariff & Other Headwinds?

Equities

Zacks Investment Research

·

August 21, 2025

·

Barchart

Johnson & Johnson JNJ faces several challenges, like potential losses from expiring drug patents, ongoing legal battles related to its talc powder and broader macroeconomic uncertainties. Here, we discuss the various headwinds that J&J faces and see if the drug and medical devices giant is well-equipped to navigate them.Stelara LOE...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.